Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 6, 2016, Pages 1528-1535

  Perkins, Rebecca B ^a   Chigurupati, Nagasudha L ^a   Apte, Gauri ^a   Vercruysse, Jessica ^a   Wall Haas, Constance ^b   Rosenquist, Anna ^b   Lee, Laura ^b   Clark, Jack A ^c   Pierre Joseph, Natalie ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HPV vaccination; parents' attitudes; physician attitudes; qualitative research; vaccine series completion

Indexed keywords

WART VIRUS VACCINE;

ACCURACY; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DECISION MAKING; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; KNOWLEDGE; PARENT COUNSELING; PHYSICIAN ATTITUDE; PUBLIC HEALTH INSURANCE; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; CITY; INTERVIEW; MASSACHUSETTS; PAPILLOMAVIRUS INFECTIONS; PARENT; PROTOCOL COMPLIANCE;

ADOLESCENT; CHILD; CITIES; FEMALE; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HUMANS; INTERVIEWS AS TOPIC; MASSACHUSETTS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS;

EID: 84961211122     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1118594     Document Type: Article

References (37)

1. ACIP Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Moral Wkly Rep 2007:56. http://origin.glb.cdc.gov.ezproxy.bu.edu/MMWR/preview/mmwrhtml/rr5602a1.htm. Accessed September15, 2014
2. ACIP. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626-9; PMID:2050859s3
3. E.A.Joura, A.R.Giuliano, O.E.Iversen, C.Bouchard, C.Mao, J.Mehlsen, E.D.Moreira, Jr, Y.Ngan, L.K.Petersen, E.Lazcano-Ponce, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372(8):711-23; PMID:25693011; http://dx.doi.org/10.1056/NEJMoa1405044
4. L.E.Markowitz, S.Hariri, C.Lin, E.F.Dunne, M.Steinau, G.McQuillan, E.R.Unger. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013; 208(3):385-93; PMID:23785124; http://dx.doi.org/10.1093/infdis/jit192
5. L.M.Niccolai, P.J.Julian, J.I.Meek, V.McBride, J.L.Hadler, L.E.Sosa. Declining rates of high-grade cervical lesions in young women in Connecticut, 2008–2011. Cancer Epidemiol Biomarkers Prev 2013; 22(8):1446-50; PMID:23704476; http://dx.doi.org/10.1158/1055-9965.EPI-13-0272
6. S.Stokley, J.Jeyarajah, D.Yankey, M.Cano, J.Gee, J.Roark, R.C.Curtis, L.Markowitz. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 - United States. MMWR Morb Mortal Wkly Rep 2014; 63(29):620-4. http://www.ncbi.nlm.nih.gov/pubmed/25055185; PMID:25055185
7. D.M.Gertig, J.M.L.Brotherton, A.C.Budd, K.Drennan, G.Chappell, A.M.Saville. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 2013; 11:227; PMID:24148310; http://dx.doi.org/10.1186/1741-7015-11-227
8. E.Herweijer, A.Leval, A.Ploner, S.Eloranta,J.F.Simard, J.Dillner, E.Netterlid, P.Sparén, L.Arnheim-Dahlström. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. JAMA 2014; 311(6):597-603; PMID:24519299; http://dx.doi.org/10.1001/jama.2014.95
9. J.Paavonen, P.Naud, J.Salmerón, C.M.Wheeler, S.N.Chow, D.Apter, H.Kitchener, X.Castellsague, J.C.Teixeira, S.R.Skinner, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374(9686):301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4
10. F.Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356(19):1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741
11. T.C.Pomfret, J.M.Gagnon, A.T.Gilchrist. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther 2011; 36(1):1-9; PMID:21198715; http://dx.doi.org/10.1111/j.1365-2710.2009.01150.x
12. SEER Stat Fact Sheets: Cervix Uteri Cancer. http://seer.cancer.gov/statfacts/html/cervix.html. Published 2013
13. R.L.Cook, J.Zhang, J.Mullins, T.Kauf, B.Brumback, H.Steingraber, C.Mallison. Factors Associated With Initiation and Completion of Human papillomavirus vaccine series among young women enrolled in medicaid. J Adolesc Heal 2010; 47(6):596-9; http://dx.doi.org/10.1016/j.jadohealth.2010.09.015
14. L.E.Widdice, D.I.Bernstein, A.C.Leonard, K.A.Marsolo, J.A.Kahn. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011; 127(1):77-84; PMID:21149425; http://dx.doi.org/10.1542/peds.2010-0812
15. L.M.Kester, G.D.Zimet, J.D.Fortenberry, J.A.Kahn, M.L.Shew. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J 2013; 17(5):879-85; PMID:22729660; http://dx.doi.org/10.1007/s10995-012-1066-z
16. F.G.Kouyoumdjian, A.Bailowitz. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatr Infect Dis J 2011; 30(8):718-9; PMID:21343841; http://dx.doi.org/10.1097/INF.0b013e3182121426
17. A.B.Alexander, N.W.Stupiansky, M.A.Ott, D.Herbenick, M.Reece, G.D.Zimet. Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr 2012; 12(1):192; PMID:23241217
18. A.B.Alexander, C.Best, N.Stupiansky, G.D.Zimet. A model of health care provider decision making about HPV vaccination in adolescent males. Vaccine 2015; 33(33):4081-6; PMID:26143612
19. C.Bordley, J.C.Vann, A.Chelminski, R.M.Kraus, P.A.Margolis. Effect of Patient Reminder / Recall Interventions on Immunization Rates A Review. J Am Med Assoc 2014; 284(14):1820-7
20. B.Cassidy, B.Braxter, D.Charron-Prochownik, E.A.Schlenk. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care 2014; 28(2):155-64; PMID:23522561
21. C.Chao, M.Preciado, J.Slezak, L.Xu. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health 2015; 56(1):85-90; PMID:25438965
22. E.O.Kharbanda, M.S.Stockwell, H.W.Fox, R.Andres, M.Lara, V.I.Rickert. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011; 29(14):2537-41; PMID:21300094
23. E.C.Matheson, A.Derouin, M.Gagliano, J.A.Thompson, J.Blood-Siegfried. Increasing HPV Vaccination Series Completion Rates via Text Message Reminders. J Pediatr Health Care 2014; 28(4):e35-9; PMID:24200295
24. M.S.Stockwell, E.O.Kharbanda, R.A.Martinez, M.Lara, D.Vawdrey, K.Natarajan, V.I.Rickert. Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations. Am J Public Health 2012; 102(2):e15-21; PMID:22390457
25. H.Groom, D.P.Hopkins, L.J.Pabst, J.Murphy Morgan, M.Patel, N.Calonge, R.Coyle, K.Dombkowski, A.V.Groom, et al. Immunization Information Systems to Increase Vaccination Rates: A Community Guide Systematic Review. J Public Health Manag Pract 2014; 97227:1-22
26. A.Kempe, A.W.Saville, L.M.Dickinson, B.Beaty, S.Eisert, D.Gurfinkel, S.Brewer, H.Shull, D.Herrero, R.Herlihy. Collaborative centralized reminder/recall notification to increase immunization rates among young children: a comparative effectiveness trial. JAMA Pediatr 2015; 169(4):365-73; PMID:25706340
27. C.M.Rand, L.P.Shone, C.Albertin, P.Auinger, J.D.Klein, P.G.Szilagyi. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007; 161:252-9; PMID:17339506
28. K.Conroy, S.L.Rosenthal, G.D.Zimet, Y.Jin, D.I.Bernstein, S.Glynn, J.A.Kahn. Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination. J Women's Heal 2009; 18(10):1679-86
29. H.B.Ferrer, C.Trotter, M.Hickman, S.Audrey. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health 2014; 14(1):700; PMID:25004868
30. N.Pourat, J.M.Jones. Role of Insurance, Income, and Affordability in Human Papillomavirus Vaccination. Am J Manag Care 2012; 18(6):320-30; PMID:22775000
31. L.Rambout, M.Tashkandi, L.Hopkins, A.C.Tricco. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med (Baltim) 2014; 58:22-32
32. D.A.Gust, N.Darling, A.Kennedy, B.Schwartz. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics 2008; 122(4):718-25; PMID:18829793; http://dx.doi.org/10.1542/peds.2007-0538
33. D.J.Opel, J.Heritage, J.A.Taylor, R.Mangione-Smith, H.S.Salas, V.Devere, C.Zhou, J.D.Robinson. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics 2013; 132(6):1037-46; PMID:24190677; http://dx.doi.org/10.1542/peds.2013-2037
34. D.D.Fredrickson, T.C.Davis, C.L.Arnold, E.M.Kennen, S.G.Hurniston, J.T.Cross, J.A.Bocchini, Jr. Childhood Immunization Refusal: Provider and Parent Perceptions. Fam Med 2004; 36(6):431-9; PMID:15181556
35. C.M.Healy, L.K.Pickering. How to communicate with vaccine-hesitant parents. Pediatrics 2011; 127 Suppl (May 2011):S127-33; PMID:21502238; http://dx.doi.org/10.1542/peds.2010-1722S
36. P.J.Smith, A.M.Kennedy, K.Wooten, D.A.Gust, L.K.Pickering. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006; 118(5):e1287-92; PMID:17079529; http://dx.doi.org/10.1542/peds.2006-0923
37. R.B.Perkins, J.A.Clark, G.Apte, J.L.Vercruysse, J.J.Sumner, C.L.Wall-Haas, A.W.Rosenquist, N.Pierre-Joseph. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics 2014; 134(3):e666-74; PMID:25136036; http://dx.doi.org/10.1542/peds.2014-0442